
Quanex Building Products (NX) has gained 7.5% in the past four weeks, and analysts' price targets suggest a potential 83.3% upside, with a mean target of $37. While the article cautions against relying solely on analyst price targets, it notes increasing optimism among analysts regarding Quanex's earnings prospects, as reflected in upward EPS estimate revisions; the Zacks Consensus Estimate for the current year has increased 2.8% over the past month.
Quanex Building Products (NX) has demonstrated recent positive momentum, with its shares gaining 7.5% over the past four weeks to close at $20.19. Wall Street analysts project a significant potential upside, with a mean short-term price target of $37, implying an 83.3% increase from the current level. This mean is derived from three targets ranging from $31 (a 53.5% upside) to $42 (a 108% upside), with a standard deviation of $5.57. While the article advises caution against relying solely on analyst price targets due to potential biases and historical inaccuracies, it underscores a more compelling factor: strengthening optimism regarding Quanex's earnings prospects. This optimism is supported by upward revisions in EPS estimates, with the Zacks Consensus Estimate for the current fiscal year having increased by 2.8% over the last month, driven by one positive revision and no negative revisions. Furthermore, NX currently holds a Zacks Rank #1 (Strong Buy), placing it in the top 5% of over 4,000 stocks ranked by Zacks, which, based on an externally-audited track record, is presented as a more conclusive indicator of potential near-term stock appreciation than price targets alone. Thus, the combination of positive earnings estimate revisions and the strong Zacks Rank suggests a favorable outlook for NX, even if the exact magnitude of upside indicated by price targets warrants careful consideration.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
moderately positive
Sentiment Score
0.50
Ticker Sentiment